India has 26 potential cases of bleeding, clotting after AstraZeneca vaccine
"There is a very miniscule but definitive risk of thromboembolic events" after being vaccinated, the data showed
A vail of the Oxford-AstraZeneca Covid-19 vaccine is seen at Basingstoke Fire Station, in Basingstoke, Britain February 4, 2021. REUTERS/Peter Cziborra/File Photo
An Indian government panel has found 26 potential cases of bleeding and clotting after administration of AstraZeneca Plc's Covishield vaccine, the health ministry said on Monday.
"There is a very miniscule but definitive risk of thromboembolic events" after being vaccinated, the data showed.
Keep updated, follow The Business Standard's Google news channel
